uric acid has been researched along with melphalan in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (57.14) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benbassat, J; Matzner, Y; Polliack, A | 1 |
| Ando, R; Hamaguchi, H; Kanemitsu, H; Marumo, F; Matsuda, O; Miyake, S; Takemura, T; Uchida, S; Yokota, T | 1 |
| Fukuda, M; Inaba, R | 1 |
| Blackwood, JM; Keller, JW; Pace, WG | 1 |
| Laszlo, J | 1 |
| Irjala, K; Laakso, M; Lahtinen, R; Mattila, K; Pelliniemi, TT; Pulkki, K; Rajamäki, A; Tienhaara, A | 1 |
| MacLeod, MC; Powell, KL; Qing, WG | 1 |
1 review(s) available for uric acid and melphalan
| Article | Year |
|---|---|
Current management of polycythemia vera and related diseases.
Topics: Allopurinol; Bloodletting; Chlorambucil; Erythropoiesis; Gout; Humans; Melphalan; Phosphorus Radioisotopes; Polycythemia Vera; Uric Acid | 1974 |
1 trial(s) available for uric acid and melphalan
| Article | Year |
|---|---|
Immunoreactive interleukin-6 and acute phase proteins as prognostic factors in multiple myeloma. Finnish Leukemia Group.
Topics: Acute-Phase Proteins; Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Calcium; Clodronic Acid; Creatinine; Female; Hemoglobins; Humans; Interleukin-6; Male; Melphalan; Middle Aged; Multiple Myeloma; Predictive Value of Tests; Prednisone; Prognosis; Regression Analysis; Risk Factors; Serum Albumin; Survival Rate; Uric Acid | 1995 |
5 other study(ies) available for uric acid and melphalan
| Article | Year |
|---|---|
Prognostic factors and the effect of alkylating agents on survival in multiple myeloma. A review of 80 patients.
Topics: Adult; Age Factors; Aged; Anemia; Blood Urea Nitrogen; Calcium; Cyclophosphamide; Drug Evaluation; Female; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin kappa-Chains; Immunoglobulin lambda-Chains; Male; Melphalan; Middle Aged; Multiple Myeloma; Myeloma Proteins; Prognosis; Remission, Spontaneous; Serum Albumin; Serum Globulins; Time Factors; Uric Acid | 1977 |
Adult Fanconi syndrome secondary to kappa-light chain myeloma: improvement of tubular functions after treatment for myeloma.
Topics: Aged; Bence Jones Protein; Fanconi Syndrome; Humans; Immunoglobulin kappa-Chains; Kidney Tubules; Male; Melphalan; Multiple Myeloma; Prednisone; Uric Acid | 1990 |
[Tumor lysis syndrome, DIC and interstitial pneumonia after treatment with prednisolone and melphalan in a patient with acute monocytic leukemia with tumor formation].
Topics: Blood Urea Nitrogen; Disseminated Intravascular Coagulation; Humans; Hyperkalemia; Leukemia, Monocytic, Acute; Male; Melphalan; Middle Aged; Phosphorus; Prednisolone; Pulmonary Fibrosis; Syndrome; Uric Acid | 1987 |
Uric acid excretion following pelvic perfusion for malignancy.
Topics: Chemotherapy, Cancer, Regional Perfusion; Fluorouracil; Humans; Melphalan; Methotrexate; Palliative Care; Pelvic Neoplasms; Tourniquets; Uric Acid | 1967 |
Kinetics of the reaction of a potential chemopreventive agent, 2,6-dithiopurine, and its major metabolite, 2,6-dithiouric acid, with multiple classes of electrophilic toxicants.
Topics: 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide; Acrolein; Anticarcinogenic Agents; Chemical Phenomena; Chemistry, Physical; Cisplatin; Kinetics; Melphalan; Nitroso Compounds; Purines; Toxins, Biological; Uric Acid | 1996 |